CAMBRIDGE, MA and TAIPEI, TAIWAN / ACCESSWIRE / September 30, 2024 / (Nasdaq:MRNA) and Cenra Healthcare, the sales and ...

CAMBRIDGE, MA and TAIPEI, TAIWAN / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Cenra Healthcare, the sales and marketing arm of Cenra Inc., today announced that the companies ...

The agreement has an initial term until July 31, 2027, and no further details on the financial terms of the deal ... about Moderna, please visit modernatx.com and connect with us on X (formerly ...

In our Looking In series, we talk to Partners from outside CEE who are keeping an eye on the region (and often pop up in our ...

Paul Parker, a former mergers and acquisitions banker turned health-care executive, is joining Flagship Pioneering Inc., the ...

We recently compiled a list of the Jim Cramer’s List of Stocks that Finished Dead Last. In this article, we are going to take ...

The US government has signed a $176 million deal with Moderna to develop an mRNA-based pandemic influenza vaccine, as reports emerge of a fifth human case of H5N1 flu linked to ongoing outbreaks ...

It has signed deals with seven vaccine suppliers - Moderna and Pfizer, as well as ones with pending ... decided to invest in ...

The US government has signed another big coronavirus vaccine supply deal, snapping up 100 million doses of Moderna’s mRNA jab for a little over $1.5 billion –around $15 per dose or $30 per course.

Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...

The rise in mRNA pharmaceuticals’ licensing agreement values suggests that this field will remain a major area for innovation ...

Advances in DNA sequencing and the vast amounts of genomic data being produced by next-generation sequencing (NGS) technology ...